ASCL2 and colitis: Furthermore, achaete-scute complex homologue 2 (Ascl2) inhibits Th17 cell differentiation and restrains their pathogenicity via promoting Blimp-1-dependent IL-10 production, whereas Ascl2 was shown to be significantly downregulated in human IBD and experimental colitis [110].